M Katharine Holloway
Overview
Explore the profile of M Katharine Holloway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrison D, Billinton A, Bock M, Doedens J, Gabel C, Holloway M, et al.
J Med Chem
. 2023 Oct;
66(21):14897-14911.
PMID: 37874905
The NLRP3 inflammasome is a component of the innate immune system involved in the production of proinflammatory cytokines. Neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral...
2.
Shanmugasundaram V, Bajorath J, Christoffersen R, Petke J, Howe W, Johnson M, et al.
J Comput Aided Mol Des
. 2022 Sep;
36(9):623-638.
PMID: 36114380
In May 2022, JCAMD published a Special Issue in honor of Gerald (Gerry) Maggiora, whose scientific leadership over many decades advanced the fields of computational chemistry and chemoinformatics for drug...
3.
Harrison D, Bock M, Doedens J, Gabel C, Holloway M, Lewis A, et al.
ACS Med Chem Lett
. 2022 Aug;
13(8):1321-1328.
PMID: 35978696
The NLRP3 inflammasome is a multiprotein complex that facilitates activation and release of the proinflammatory cytokines interleukin-1β (IL-1β) and IL-18 in response to infection or endogenous stimuli. It can be...
4.
Beshore D, Adam G, Barnard R, Burlein C, Gallicchio S, Holloway M, et al.
ACS Med Chem Lett
. 2021 Apr;
12(4):540-547.
PMID: 33854701
A novel series of histone deacetylase (HDAC) inhibitors lacking a zinc-binding moiety has been developed and described herein. HDAC isozyme profiling and kinetic studies indicate that these inhibitors display a...
5.
Yu W, Liu J, Clausen D, Yu Y, Duffy J, Wang M, et al.
J Med Chem
. 2021 Apr;
64(8):4709-4729.
PMID: 33797924
We describe the discovery of histone deacetylase (HDACs) 1, 2, and 3 inhibitors with ethyl ketone as the zinc-binding group. These HDACs 1, 2, and 3 inhibitors have good enzymatic...
6.
Bukhtiyarova M, Cook E, Hancock P, Hruza A, Shaw A, Adam G, et al.
ACS Med Chem Lett
. 2021 Jan;
12(1):99-106.
PMID: 33488970
By employing a phenotypic screen, a set of compounds, exemplified by , were identified which potentiate the ability of histone deacetylase inhibitor vorinostat to reverse HIV latency. Proteome enrichment followed...
7.
Liu J, Yu Y, Kelly J, Sha D, Alhassan A, Yu W, et al.
ACS Med Chem Lett
. 2020 Dec;
11(12):2476-2483.
PMID: 33335670
The selectivity of histone deacetylase inhibitors (HDACis) is greatly impacted by the zinc binding groups. In an effort to search for novel zinc binding groups, we applied a parallel medicinal...
8.
Liu J, Kelly J, Yu W, Clausen D, Yu Y, Kim H, et al.
ACS Med Chem Lett
. 2020 Jul;
11(7):1476-1483.
PMID: 32676157
HIV persistence in latently infected, resting CD4 T cells is broadly considered a barrier to eradicate HIV. Activation of the provirus using latency-reversing agents (LRAs) followed by immune-mediated clearance to...
9.
Li Y, Gao Y, Holloway M, Wang R
J Chem Inf Model
. 2020 May;
60(9):4359-4375.
PMID: 32401510
The important role of water molecules in protein-ligand binding energetics has attracted wide attention in recent years. A range of computational methods has been developed to predict the favorable locations...
10.
Thompson W, Ghosh A, Holloway M, Lee H, Munson P, Schwering J, et al.
J Am Chem Soc
. 2018 Oct;
115(2):801-803.
PMID: 30364398
The blockade of the HIV protease has become a major target in the search for an effective therapy for AIDS. While many reports of potent HIV-1 inhibitors have appeared recently,...